Evaluation of Symptom Improvement through the Use of a Smartphone Application in Patients with Temporomandibular Disorder (TMD).

Management of temporomandibular disorder through self-monitoring application use and cognitive behavioral therapy for temporomandibular disorder patients and evaluation of symptom improvement effect : Pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008889

Enrollment

Registered

2023-10-20

Start date

2022-05-13

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Smartphone software application) : The control group receives the standard clinical treatment, known as 'Treatment as Usual (TAU)', and is provided with brochures or educational counseling duri

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Adults aged 19 to 65 years old. ? Patients diagnosed with temporomandibular disorder (TMD) who visited the Seoul National University Dental Hospital. ? Patients diagnosed with muscular disorders, temporomandibular joint internal derangements, and temporomandibular joint arthritis based on clinical and radiological examinations. ? Individuals who voluntarily decided to participate in this clinical trial and provided written consent.

Exclusion criteria

Exclusion criteria: ? Individuals not diagnosed with temporomandibular disorder (TMD) based on clinical and radiological examinations. ? Individuals with intrinsic diseases of the temporomandibular joint: ankylosis, tumors. ? Individuals with traumatic conditions of the temporomandibular joint: mandibular condyle fractures, major facial trauma (e.g., from traffic accidents, assaults, etc.). ? Individuals suffering from rare muscular diseases such as severe myasthenia gravis, Eaton-Lambert syndrome, and amyotrophic lateral sclerosis. ? Individuals with serious metabolic diseases like severe hypertension or diabetes. ? Individuals diagnosed with neurological disorders (e.g., Parkinson's, Alzheimer's) or psychiatric disorders. ? Individuals currently taking medications for sleep disorders (e.g., benzodiazepines, muscle relaxants, tricyclic antidepressants, etc.), or potentially consuming unauthorized drugs, alcohol, or narcotics. ? Individuals undergoing dental orthodontics or wearing other oral devices. ? Cases where the participant withdraws their consent. ? Any other individuals deemed inappropriate for the study by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Pain : Numeric Rating Scale (NRS) ;Mouth opening (mm)	—

Secondary

Measure	Time frame
Jaw Functional Limitation Scale (JFLS) -20;Oral Behavior checklist; Patient Health Questionnaire (PHQ) -4	—

Countries

Korea, Republic of

Contacts

Public ContactSang-Yoon Park

Hallym University Medical Center

psypjy0112@naver.com+82-31-380-3870

Outcome results